Karen C. Wolff

Statistics

Publications

Citations

1.6K

H-Index

Active since

1999

Affiliations

Genomics Institute of the Novartis Research Foundation(Current)

California Institute for Biomedical Research

Scripps Research Institute

UC San Diego Health System

University of California, Santa Barbara

Karen C. Wolff is an author at Genomics Institute of the Novartis Research Foundation specializing in virology, drug discovery, and antiviral pharmacology.

Publications per year

1999–2024

Publications

Design, synthesis and biological evaluations of novel oxindoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. Part I

Tao Jiang, Kelli Kuhen, Karen C. Wolff et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 298 citations

Pharmacy, Medicinal Chemistry, Pharmacology +16

Mutations in an Auxin Receptor Homolog AFB5 and in SGT1b Confer Resistance to Synthetic Picolinate Auxins and Not to 2,4-Dichlorophenoxyacetic Acid or Indole-3-Acetic Acid in Arabidopsis

Terence A. Walsh, Roben Neal, Ann Owens Merlo et al. · PLANT PHYSIOLOGY · 2006 · 224 citations · Full text

Life Sciences, Plant Biology, Plant Sciences +17

Design, synthesis, and biological evaluations of novel oxindoles as HIV-1 non-nucleoside reverse transcriptase inhibitors. Part 2

Tao Jiang, Kelli Kuhen, Karen C. Wolff et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 201 citations

Medicine, Medicinal Chemistry, Pharmacology +16

Drug repurposing screens identify chemical entities for the development of COVID-19 interventions

Malina A. Bakowski, Nathan Beutler, Karen C. Wolff et al. · Nature Communications · 2021 · 130 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication

Gustavo Garcia, Arun Sharma, Arunachalam Ramaiah et al. · Cell Reports · 2021 · 119 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

1–5 of 18